Publication: Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study
dc.contributor.author | BOZKURT, SÜHEYLA | |
dc.contributor.authors | Barisik, Nagehan O.; Bozkurt, Suheyla; Gumus, Mahmut; Kaygusuz, Isik; Karadayi, Nimet; Bas, Emine; Bayik, Mahmut; Tecimer, Tulay | |
dc.date.accessioned | 2022-03-14T09:26:30Z | |
dc.date.available | 2022-03-14T09:26:30Z | |
dc.date.issued | 2010-12 | |
dc.description.abstract | Background: Cyclooxygenase (cox) is the rate-limiting enzyme, which catalyzes the conversion of arachidonic acid into prostaglandins and contributes to the inflammatory process. Cyclooxygenase-2 (cox-2), which is one of the two isoforms, plays a role in tumor progression and carcinogenesis. p53 contributes to apoptosis, DNA renewal and cell cycle. Studies concerning the relationship of cox-2 and p53 expressions and carcinogenesis are available, but the association between cox-2 and p53 in Hodgkin lymphoma (HL) is not exactly known. In our study, we examined the association of cox-2 and p53 expression, with age, stage, histopathological subtype, and survival in HL. We also examined correlation between cox-2 and p53 expression. Methods: Cox-2 and p53 expressions in Hodgkin-Reed Sternberg cells (HRS) were examined in 54 patients with HL depending on cox-2 expression, stained cases were classified as positive, and unstained cases as negative. Nuclear staining of HRS cells with p53 was evaluated as positive. The classifications of positivity were as follows: negative if<10%; (1+) if 10-25%; (2+) if 25-50%; (3+) if 50-75%, (4+) if >75%. Results: Cox-2 and p53 expressions were found in 49 (80%) and 29 (46%) patients, respectively. There were differences between histological subtypes according to cox-2 expression (p = 0.012). Mixed cellular (MC) and nodular sclerosing (NS) subtypes were seen most of the patients and cox-2 expression was evaluated mostly in the mixed cellular subtype. There were no statistically significant relationships between p53 and the histopathological subtypes; or between p53, cox-2 and the factors including stage, age and survival; or between p53 and cox-2 expression (p > 0.05). Conclusion: Considering the significant relationship between the cox-2 expression and the subtypes of HL, cox-2 expression is higher in MC and NS subtypes. However the difference between these two subtypes was not significant. This submission must be advocated by studies with large series | |
dc.identifier.doi | 10.1186/1746-1596-5-19 | |
dc.identifier.eissn | 1746-1596 | |
dc.identifier.pubmed | 20346139 | |
dc.identifier.uri | https://hdl.handle.net/11424/243125 | |
dc.identifier.wos | WOS:000276609900001 | |
dc.language.iso | eng | |
dc.publisher | BMC | |
dc.relation.ispartof | DIAGNOSTIC PATHOLOGY | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | CYCLOOXYGENASE-2 GENE-EXPRESSION | |
dc.subject | REED-STERNBERG CELLS | |
dc.subject | BCL-2 EXPRESSION | |
dc.subject | UP-REGULATION | |
dc.subject | MOUSE MODEL | |
dc.subject | P53 | |
dc.subject | CANCER | |
dc.subject | RISK | |
dc.subject | ANGIOGENESIS | |
dc.subject | INHIBITION | |
dc.title | Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | aa138643-27ab-4120-a683-6396caa7a8c1 | |
local.import.package | SS16 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.journal.articlenumber | 19 | |
local.journal.numberofpages | 7 | |
oaire.citation.title | DIAGNOSTIC PATHOLOGY | |
oaire.citation.volume | 5 | |
relation.isAuthorOfPublication | dd039cf9-dfb8-4af0-b879-0b88c3a852fa | |
relation.isAuthorOfPublication.latestForDiscovery | dd039cf9-dfb8-4af0-b879-0b88c3a852fa |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Barisik et al. - 2010 - Expression and prognostic significance of cox-2 an.pdf
- Size:
- 1.43 MB
- Format:
- Adobe Portable Document Format